President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
50-Year Medalist StudyClinical Research
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

Professional Education

Joslin Diabetes Center is a leader in continuing education for healthcare professionals. Joslin's CME and CE activities promote the highest standards of care, drawing on up-to-date medical literature as well as cutting-edge research conducted at Joslin to provide current, relevant, and evidence-based findings from Joslin faculty and other experts. Our mission is to help providers offer their patients optimal management of diabetes and its related conditions, improved health outcomes, and enhanced quality of life.

Upcoming Live Activities

Join us for the series The Evolution of Insulin Replacement: New Perspectives and Clinical Applications

Presented by Joslin Diabetes Center in Joint Providership with PlatformQ Health Education, LLC. All sessions will be held as video webinars online. We will post the link to register for these activities shortly.

Thursday, September 14, 2017, from 3:00 PM EST – 4:00 PM EST
• Insulin Options for Diabetes: Update on their Evolution

Thursday, October 19, 2017, from 1:00 PM EST – 2:00 PM EST
• Advancing to Insulin Therapy for Type 2 Diabetes: The Impact of the New Insulin Options

Thursday, November 30, 2017, from 12:00 PM EST – 2:00 PM EST
• 12:00 PM – 1:00 PM EST: Physiologic Insulin Replacement: Practical Approaches for the Primary Care Provider
• 1:00 PM – 2:00 PM EST: The Evolution of Glycemic Monitoring and Insulin Delivery Devices: Why the Primary Care Provider Should Understand the Options

These activities are supported by educational grants from Novo Nordisk Inc. and Medtronic, Inc.

Current Enduring Activities

Click on the title of each activity to begin.

Concentrated Insulins in Clinical Practice: Pharmacology and Treatment Designs

Topics Of Interest:
•  Pathophysiology and clinical manifestations of insulin resistance
•  Pharmacokinetics and pharmacodynamics of concentrated insulins used to treat people with diabetes, particularly in patients with insulin resistance
•  Indications and use of concentrated insulins in patients with type 2 diabetes
•  Identification of patient, provider, and health care system barriers to the use of concentrated insulins, and methods to overcome these barriers

This activity is supported by an educational grant from Lilly USA, LLC and is offered through our partner Platform Q Health. Expiration date: December 21, 2017.

Virtual Grand Rounds Series: Dyslipidemia and Diabetes

Topics of Interest:
•  Key changes in the updated treatment guidelines for dyslipidemia
•  Strategies to address residual CV risk beyond statin therapy
•  Indications for newer non-statin drug therapies in patients with high lipid–related CVD risk
•  Pharmacology, approved indications, and optimal use of PCSK9 inhibitors in patients at high risk for CVD events

This activity is supported by an educational grant from Amgen and is offered through our partner Platform Q Health. Expiration date: September 29, 2017.

Proven Success with Educational Outcomes


Joslin Diabetes Center has been at the forefront of measuring educational outcomes for our activities, based on the levels defined by Moore et al.1 We have been involved in several specific projects that measure the impact of our educational activities on clinician performance measures (Level 5) and patient outcomes measures (Level 6). Please click here to read about one of these initiatives entitled Targeting Type 2 Diabetes: Achieving Glycemic and Cardiometabolic Goals. This initiative was supported by educational grants from GlaxoSmithKline LLC and Merck Sharpe and Dohme Corp.

1 Moore DE Jr, Green JS, Gallis HA. Achieving desired results and improved outcomes: integrating planning and assessment throughout learning activities. J Contin Educ Health Prof. 2009;29(1):1-15.


Joslin at World Congress for CPD 2016

Joslin recently presented a session and a poster based on the performance improvement grant entitled Comparison of Methods for Assessing Clinical Performance Improvement in Primary Care.

View the poster here

Joslin Clinical Guidelines

To assist physicians and other healthcare professionals in managing the care of their patients with diabetes, Joslin offers approved clinical guidelines on a variety of topics including Adult Diabetes, Pharmacological Management of Type 2 Diabetes, and Continuous Glucose Monitors.

ACCME Awards Joslin CME Accreditation with Commendation